SCENESSE 16 mg implant
CUV105
Phase 3 small_molecule active
Quick answer
SCENESSE 16 mg implant for Vitiligo is a Phase 3 program (small_molecule) at Clinuvel Europe Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Clinuvel Europe Limited
- Indication
- Vitiligo
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active